Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-16-010332
Filing Date
2016-05-16
Accepted
2016-05-16 12:53:56
Documents
55
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q biei_10q.htm 10-Q 315401
2 CERTIFICATION biei_ex311.htm EX-31.1 7637
3 CERTIFICATION biei_ex312.htm EX-31.2 7537
4 CERTIFICATION biei_ex321.htm EX-32.1 3473
5 CERTIFICATION biei_ex322.htm EX-32.2 3436
  Complete submission text file 0001477932-16-010332.txt   2364713

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT biei-20160331.xml EX-101.INS 502819
7 XBRL TAXONOMY EXTENSION SCHEMA biei-20160331.xsd EX-101.SCH 45509
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE biei-20160331_cal.xml EX-101.CAL 34775
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE biei-20160331_def.xml EX-101.DEF 51180
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE biei-20160331_lab.xml EX-101.LAB 201690
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biei-20160331_pre.xml EX-101.PRE 126987
Mailing Address P.O. BOX 31374 EL PASO TX 79930
Business Address P.O. BOX 31374 EL PASO TX 79930 814 786 8849
PREMIER BIOMEDICAL INC (Filer) CIK: 0001515740 (see all company filings)

EIN.: 272635666 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54563 | Film No.: 161652244
SIC: 2836 Biological Products, (No Diagnostic Substances)